Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Global, G-TL, and Cornell Media for Embryo Culture
NCT03687697Phase 4Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Apr 2018
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Embryo development at Day 5. Planned start Apr 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT03687697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687697.